Voloridge Investment Management
CELG

Voloridge Investment Management’s Celgene Corp CELG Stock Holding History

Voloridge Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-159,169
Closed -$15.8M – 1486
2019
Q3 		$15.8M Sell
159,169
-192,048
-55% -$18.2M 0.27% 59
2019
Q2 		$32.5M Buy
+351,217
New +$33.4M 0.9% 14
2018
Q3 		– Sell
-1,111,291
Closed -$88.3M – 544
2018
Q2 		$88.3M Buy
+1,111,291
New +$92.3M 2.36% 8
2017
Q4 		– Sell
-380,872
Closed -$55.5M – 670
2017
Q3 		$55.5M Sell
380,872
-68,331
-15% -$9.31M 1.24% 10
2017
Q2 		$58.3M Buy
+449,203
New +$55M 1.45% 11
2016
Q2 		– Sell
-544,272
Closed -$54.5M – 460
2016
Q1 		$54.5M Buy
+544,272
New +$56M 1.28% 13

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Voloridge Investment Management's CELG Position: Q4 2019 in Review

Voloridge Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 159,169 shares — an estimated $15.8M sold.

Voloridge Investment Management first reported a position in CELG in Q1 2016 and held it in 6 quarters. The position peaked at $88.3M in Q2 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Voloridge Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Voloridge Investment Management sold 159,169 Celgene Corp shares in Q4 2019, an estimated $15.8M.
  • Voloridge Investment Management first reported a position in Celgene Corp in Q1 2016 and held it in 6 quarters.
  • Voloridge Investment Management's Celgene Corp position peaked at $88.3M in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Voloridge Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.